Topiramate: antipsychotic-induced weight gain. 2014

Joyce A Generali, and Dennis J Cada
Editor-in-Chief, Hospital Pharmacy, and Clinical Professor, Emeritus, Department of Pharmacy Practice, University of Kansas, School of Pharmacy , Kansas City/Lawrence , Kansas , e-mail: jgeneral@ku.edu.

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

UI MeSH Term Description Entries

Related Publications

Joyce A Generali, and Dennis J Cada
December 2001, Journal of the American Academy of Child and Adolescent Psychiatry,
Joyce A Generali, and Dennis J Cada
January 2012, Indian journal of psychological medicine,
Joyce A Generali, and Dennis J Cada
January 2007, American journal of therapeutics,
Joyce A Generali, and Dennis J Cada
October 2005, Psychiatry and clinical neurosciences,
Joyce A Generali, and Dennis J Cada
September 2005, Diabetes, obesity & metabolism,
Joyce A Generali, and Dennis J Cada
January 2006, Psychiatria polska,
Joyce A Generali, and Dennis J Cada
January 2006, Psychiatria polska,
Joyce A Generali, and Dennis J Cada
August 2004, Psychopharmacology,
Joyce A Generali, and Dennis J Cada
May 2006, Medical science monitor : international medical journal of experimental and clinical research,
Joyce A Generali, and Dennis J Cada
October 2017, Journal of the American Academy of Child and Adolescent Psychiatry,
Copied contents to your clipboard!